Nucleotide sequence of v-rel: the oncogene of reticuloendotheliosis virus.
about
Both N- and C-terminal domains of RelB are required for full transactivation: role of the N-terminal leucine zipper-like motifGenetic characterization of human c-rel sequencesA novel mitogen-inducible gene product related to p50/p105-NF-kappa B participates in transactivation through a kappa B siteInteraction of the COOH-terminal transactivation domain of p65 NF-kappa B with TATA-binding protein, transcription factor IIB, and coactivatorsNF-kappa B subunit-specific regulation of the interleukin-8 promoterThe mongoose, the pheasant, the pox, and the retrovirusDiscovery of retroviral homologs in bats: implications for the origin of mammalian gammaretrovirusesThe v-rel oncogene product is complexed to a 40-kDa phosphoprotein in transformed lymphoid cells.AP-1 factors play an important role in transformation induced by the v-rel oncogene.Multiple mutations contribute to the oncogenicity of the retroviral oncoprotein v-Rel.The second oncogene mil of avian retrovirus MH2 is related to the src gene family.Mapping of a serine-rich domain essential for the transcriptional, antiapoptotic, and transforming activities of the v-Rel oncoprotein.The oncoprotein Bcl-3 can facilitate NF-kappa B-mediated transactivation by removing inhibiting p50 homodimers from select kappa B sites.Cell transformation by v-Rel reveals distinct roles of AP-1 family members in Rel/NF-kappaB oncogenesis.Mechanism of telomerase activation by v-Rel and its contribution to transformation.Molecular cloning of cDNA encoding the Xenopus homolog of mammalian RelB.Autoregulation of the NF-kappa B transactivator RelA (p65) by multiple cytoplasmic inhibitors containing ankyrin motifsExpression of the oncogene of avian reticuloendotheliosis virus in Escherichia coli and identification of the transforming protein in reticuloendotheliosis virus T-transformed cells.Mutations in the DNA-binding and dimerization domains of v-Rel are responsible for altered kappa B DNA-binding complexes in transformed cellsAvian I kappa B alpha is transcriptionally induced by c-Rel and v-Rel with different kineticsMutual regulation of the transcriptional activator NF-kappa B and its inhibitor, I kappa B-alphaRetroviral transformation in vitro of chicken T cells expressing either alpha/beta or gamma/delta T cell receptors by reticuloendotheliosis virus strain T.Transcription and cancer.Isolation of chicken cellular DNA sequences with homology to the region of viral oncogenes that encodes the tyrosine kinase domain.v-rel induces expression of three avian immunoregulatory surface receptors more efficiently than c-rel.Evolution of the oncogenic potential of v-rel: rel-induced expression of immunoregulatory receptors correlates with tumor development and in vitro transformationTransformation of avian fibroblasts overexpressing the c-rel proto-oncogene and a variant of c-rel lacking 40 C-terminal amino acids.In vivo evolution of c-rel oncogenic potential.NF-kappa B p100 is one of the high-molecular-weight proteins complexed with the v-Rel oncoprotein in transformed chicken spleen cells.Differential pp40I kappa B-beta inhibition of DNA binding by rel proteinsvRel is an inactive member of the Rel family of transcriptional activating proteins.Kappa B site-dependent activation of the interleukin-2 receptor alpha-chain gene promoter by human c-RelOncogenic transformation by vrel requires an amino-terminal activation domainCharacterization of a novel promoter insertion in the c-rel locus.A protein kinase-A recognition sequence is structurally linked to transformation by p59v-rel and cytoplasmic retention of p68c-relTransactivation of gene expression by nuclear and cytoplasmic rel proteins.Reticuloendotheliosis virus REV-T(REV-A)-induced neoplasia: development of tumors within the T-lymphoid and myeloid lineages.RelB, a new Rel family transcription activator that can interact with p50-NF-kappa B.Identification of a rel-related protein in the nucleus during the S phase of the cell cycle.Expression of v-rel induces mature B-cell lines that reflect the diversity of avian immunoglobulin heavy- and light-chain rearrangements.
P2860
Q24606830-DEBE60DE-5A49-4603-8A06-76D5582E7AFAQ24617290-82E83FE0-4EFF-4565-ADCA-DE3373E65A66Q24630534-AD58EA2C-14D3-4982-9F96-DC029CEAE23AQ28299369-230EF884-2FAF-411B-92ED-95A839315031Q28646361-333C3021-8750-49A4-9312-0B24326CB02BQ28681409-9F767BA2-0E88-4ACB-8E53-1120578FC5D0Q28730771-61B6A0DD-32B7-420E-938A-38FB685925A5Q33566355-01D3E7B6-BDC0-4BCD-B6EA-985267471044Q33786606-8A7244BE-371D-49D7-A930-C81E2B4B5CBFQ33797168-F7C37D47-F069-46B0-A6C4-06F55D917277Q33939568-55BDBFE0-C6BC-4D9A-A9A3-0A9A4560E930Q33957101-81D3E7E9-8A8F-41FA-A21D-D3925B7789A8Q34061332-B8FD4032-0870-4D4A-98CB-A34F6FB98ADAQ34101480-69C2994F-015C-40D6-9A30-FEA9A28F0CCAQ34233162-779CE70D-87A2-4F62-A2BC-A77DD9FF1FCDQ34781115-441AAD47-1133-44EC-88A8-7AC9EA3225CDQ35043602-71951788-B74B-452D-95B3-807DECFF1DF6Q35589279-FB09D42B-02A2-4431-8879-209298BDB1DDQ35839572-CE9032EF-4EB6-4703-A9EB-20CAE2C32FF9Q35845620-4CDD31B9-B9C9-4440-BC2D-44EB20EE337AQ36180990-B6C27DBD-2DAB-4130-92A8-805D9AB3D66FQ36361430-E9545BF4-9DDA-4CC7-8647-5CE7C9B99648Q36385496-687DB719-B157-4E58-A6E9-AACE78610460Q36425965-5CDD132E-7457-46CE-B374-5DCE2DF63FC2Q36619719-1F186B0A-2922-4877-A67F-AB8349FDBA19Q36630907-CAA71401-3792-46C3-9E44-B576954987C7Q36631040-80852EEF-25AD-476B-8BB8-A161DE0DD718Q36631973-68284D62-198F-4F1C-A678-142E9B5B8DF3Q36655517-3D3F0CC0-DCA1-4FEE-A337-D9F5678C8E8FQ36676544-09395FFF-EF9E-417E-B5A8-55BD20F7948EQ36694853-5A656CBB-B6E6-4D47-BB67-B9F0EC372CD4Q36700950-24A411DB-ACB9-4812-B2AC-0C2A71199EB4Q36710704-A2518D02-C845-44CB-8C13-CAAC36A7A4F0Q36724568-00E498AC-A41D-40C5-9402-DE8389322604Q36742494-188EF971-A18A-452F-8A4B-7716EDFAFDB0Q36762152-0B6FCFDB-5EE0-4626-B9F3-3E2A4BE3AFDAQ36796151-60D4B0E0-FD08-44AE-9AEA-7DA6673E0ED6Q36812702-D14F94C0-98D7-42EF-A101-C3843ADE4B6AQ36823461-AE6056EE-503E-47B9-8AE9-5CB4F8C30C33Q36850598-22A6067E-A7B6-45C2-BB94-6F036EFE101D
P2860
Nucleotide sequence of v-rel: the oncogene of reticuloendotheliosis virus.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on October 1983
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Nucleotide sequence of v-rel: the oncogene of reticuloendotheliosis virus.
@en
Nucleotide sequence of v-rel: the oncogene of reticuloendotheliosis virus.
@nl
type
label
Nucleotide sequence of v-rel: the oncogene of reticuloendotheliosis virus.
@en
Nucleotide sequence of v-rel: the oncogene of reticuloendotheliosis virus.
@nl
prefLabel
Nucleotide sequence of v-rel: the oncogene of reticuloendotheliosis virus.
@en
Nucleotide sequence of v-rel: the oncogene of reticuloendotheliosis virus.
@nl
P2093
P2860
P356
P1476
Nucleotide sequence of v-rel: the oncogene of reticuloendotheliosis virus.
@en
P2093
R M Stephens
R R Hiebsch
R V Gilden
P2860
P304
P356
10.1073/PNAS.80.20.6229
P407
P577
1983-10-01T00:00:00Z